Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • English
  • Español (Spanish)
  1. Home
  2. Search Results
Search Results 581 – 600 of 3231
Perinatal HIV Clinical Guidelines
https://clinicalinfo.hiv.gov/guidelines/perinatal
HIV Clinical Guidelines: Pediatric Opportunistic Infections
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections
HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections
HIV Clinical Guidelines: Pediatric ARV
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv
Guidance for Caring for People With HIV Displaced by Disasters
https://clinicalinfo.hiv.gov/guidelines/guidance-caring-people-hiv-displaced-disasters
Nondiscrimination Notice
https://clinicalinfo.hiv.gov/nondiscrimination-notice
Aviso de no discriminación
https://clinicalinfo.hiv.gov/nondiscrimination-notice
Disclaimers
https://clinicalinfo.hiv.gov/disclaimers
El descargo de responsabilidad
https://clinicalinfo.hiv.gov/disclaimers
3BNC117
https://clinicalinfo.hiv.gov/drugs/3bnc117/health-professional
3BNC117
https://clinicalinfo.hiv.gov/drugs/3bnc117/patient
3BNC117
https://clinicalinfo.hiv.gov/drugs/3bnc117/patient
Abacavir / Dolutegravir / Lamivudine
https://clinicalinfo.hiv.gov/drugs/abacavir-dolutegravir-lamivudine/fda-label
Abacavir / Dolutegravir / Lamivudine
https://clinicalinfo.hiv.gov/drugs/abacavir-dolutegravir-lamivudine/patient
Abacavir / Dolutegravir / Lamivudina
https://clinicalinfo.hiv.gov/drugs/abacavir-dolutegravir-lamivudine/patient
Abacavir / Lamivudine
https://clinicalinfo.hiv.gov/drugs/abacavir-lamivudine/fda-label
Abacavir / Lamivudine
https://clinicalinfo.hiv.gov/drugs/abacavir-lamivudine/patient
Abacavir / Lamivudina
https://clinicalinfo.hiv.gov/drugs/abacavir-lamivudine/patient
Abacavir
https://clinicalinfo.hiv.gov/drugs/abacavir/fda-label
Abacavir
https://clinicalinfo.hiv.gov/drugs/abacavir/patient

Pagination

  • First page «
  • Previous page ‹
  • …
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Current page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • …
  • Next page ›
  • Last page »

CONNECT WITH US

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • Sponsors
  • Nondiscrimination Notice
  • Accessibility
  • Disclaimers
  • Sitemap
  • Privacy Policy
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.